AYAigul P. Yermagambetova

Aigul P. Yermagambetova

*This is an algorithmically generated author record based on publicly available information.

Aigul P. Yermagambetova has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COMPREHENSIVE OUTPATIENT REHABILITATION IN THE EARLY RECOVERY PERIOD AFTER STROKE: A RANDOMISED CONTROLLED TRIAL

    by A.O. Baizullina, L.M. Zhamaliyeva, A.P. Yermagambetova, I.H.B. Mohamed, Zh.U. Urasheva, Z.S. Khairullina, Zh.N. Gaisiyeva

    Relevance. At the third (outpatient) stage of rehabilitation in primary health care (PHC), recovery after stroke depends to a large extent on how active the patient is. Post-stroke fatigue, depressive symptoms, and fear of movement limit participation in rehabilitation, while psychotherapeutic support at this stage is available only to a limited extent. The aim: to evaluate the effectiveness of a physical rehabilitation programme incorporating selected cognitive-behavioural therapy techniques, compared with a standard rehabilitation programme, in patients after stroke at the third (outpatient) stage of rehabilitation. Methods. Design:randomised controlled parallel-group trial (1:1). Setting: third (outpatient) stage of rehabilitation, Aktobe, Republic of Kazakhstan, June 2026 – September 2026. Participants: 108 patients in the early recovery period after stroke (54 in the intervention group and 54 in the control group). Intervention: the intervention group received a comprehensive physical rehabilitation programme with integrated CBT techniques (an educational component, strategies to overcome kinesiophobia, behavioural activation, and activity pacing), delivered as 4 individual 60-minute weekly sessions; the first session was held in person and the remaining three via video link. The control group followed the standard rehabilitation programme set out in the clinical protocol of the Ministry of Health of the Republic of Kazakhstan. Main outcome measures:Barthel Index, modified Rankin Scale (mRS), Fatigue Assessment Scale (FAS), PHQ-9 and GAD-7, assessed at baseline (T0) and at the end of the course (T1). Data were analysed using the Mann - Whitney U test, analysis of covariance (ANCOVA) and ordinal logistic regression. Results. Ofthe 108 randomised patients, 107 were included in the analysis (53 in the intervention group and 54 in the control group). The groups were comparable at baseline (p > 0.05). After adjustment for baseline values, the intervention group had a Barthel Index 6.26 points higher (95% CI 3.36–9.15; p < 0.001; η²p = 0.150), an FAS score 4.17 points lower (95% CI 2.81–5.53; p < 0.001; η²p = 0.262), and a PHQ-9 score 1.78 points lower (95% CI 1.35–2.21; p < 0.001; η²p = 0.389) than the control group. Participation in the programme increased the odds of a more favourable Barthel Index category (OR = 3.45; 95% CI 1.28–9.34; p = 0.015) and reduced the odds of a worse mRS score (OR = 0.27; 95% CI 0.10–0.72; p = 0.009). Anxiety symptoms were not affected (p = 0.233). Conclusion. Integrating selected CBT techniques into physical rehabilitation sessions at the third stage of rehabilitation in a primary care setting was superior to the standard programme in improving functional independence and reducing post-stroke fatigue and depressive symptoms. Актуальность. На третьем (амбулаторно-поликлиническом) этапе реабилитации в условиях первичной медико-санитарной помощи (ПМСП) восстановление после инсульта во многом зависит от активности самого пациента. Постинсультная утомляемость, депрессивные симптомы и страх движения ограничивают его участие в реабилитации, а психотерапевтическая помощь на этом этапе доступна лишь в ограниченном объеме. Цель: оценить эффективность программы физической реабилитации с интеграцией отдельных техник когнитивно-поведенческой терапии (КПТ) по сравнению со стандартной программой реабилитации у пациентов после инсульта на третьем (амбулаторно-поликлиническом) этапе. Методы. Дизайн: рандомизированное контролируемое исследование с параллельными группами (1:1). Условия проведения: третий (амбулаторно-поликлинический) этап реабилитации, г. Актобе, Республика Казахстан, июнь 2026 – сентябрь 2026 г. Участники: 108 пациентов в раннем восстановительном периоде инсульта (54 в основной и 54 в контрольной группе). Вмешательство: пациенты основной группы проходили комплексную программу физической реабилитации (кинезотерапия, ЛФК) с интеграцией отдельных элементов КПТ (образовательный компонент, преодоление кинезиофобии, поведенческая активация и дозирование активности) – 4 индивидуальных занятия по 60 минут 1 раз в неделю, первое занятие проводилось очно, последующие три – по видеосвязи. Контрольная группа занималась по стандартной программе реабилитации, предусмотренной клиническим протоколом МЗ РК. Основные исходы: индекс Бартела, модифицированная шкала Рэнкина (mRS), шкала утомляемости FAS, PHQ-9 и GAD-7, оцененные исходно (Т0) и по завершении курса (Т1). Применяли U-критерий Манна – Уитни, ковариационный анализ (ANCOVA) и порядковую...

  • IDENTIFYING HIGH-RISK GROUPS FOR STROKE RECURRENCE: ONE-YEAR OUTCOMES FROM A PROSPECTIVE COHORT

    by A.O. Baizullina, L.M. Zhamaliyeva, A.U. Nurtazina, A.P. Yermagambetova

    Relevance: Stroke recurrence remains a major contributor to long-term morbidity and mortality. Despite improvements in acute management and secondary prevention, the risk of relapse within the first year remains clinically significant. Identifying predictors of recurrence is critical for tailoring follow-up strategies and optimizing preventive care. The aim of this study is to analyze the survival of stroke patients and evaluate the impact of risk factors. Materials and Methods: This prospective cohort observational study included 150 stroke patients admitted to two multidisciplinary hospitals between February and July 2024. Eligible patients were aged ≥ 18 years, admitted within 48 hours of symptom onset, and followed for 12 months after discharge. The primary endpoint was recurrence-free survival (RFS), defined as the time from discharge to recurrent stroke or death. Survival probabilities, subgroup differences, and independent predictors of recurrence were evaluated. Results: During the follow-up period, a recurrent stroke was recorded in 10 out of 150 patients (6,7%). According to the Kaplan-Meier analysis, the 12-month recurrence-free survival rate was 90,2%, corresponding to an estimated 12-month cumulative probability of recurrence of 9,8%. Most events occurred in the second half of follow-up. Patients with diabetes mellitus had significantly lower RFS than those without (86.8% vs.97.3%, p = 0.009). Patients with a history of recurrent stroke also had poorer outcomes compared to first-time stroke cases (84.0% vs. 96.8%, p = 0.007). Cox regression identified recurrent stroke at admission (HR = 3.83, 95% CI 1.09–13.44, p = 0.036) and diabetes mellitus (HR = 3.84, 95% CI 1.06–13.84, p = 0.040) as independent predictors of recurrence. Gender was not significantly associated with outcomes. Conclusion: One-year recurrence-free survival after stroke was favorable overall; however, patients with diabetes and those admitted with a recurrent stroke had approximately 3,8-fold higher and 3,8-fold higher HR, respectively. Актуальность: Рецидив инсульта остается одной из основных причин долгосрочной заболеваемости и смертности. Несмотря на улучшение методов оказания неотложной помощи и вторичной профилактики, риск рецидива в течение первого года остается клинически значимым. Выявление предикторов рецидива имеет решающее значение для разработки стратегий последующего наблюдения и оптимизации профилактической помощи. Цель исследования: анализ выживаемости пациентов, перенесших инсульт, и оценка влияния факторов риска. Материалы и методы: В это проспективное когортное обсервационное исследование были включены 150 пациентов с инсультом, госпитализированных в две многопрофильные больницы в период с февраля по июль 2024 года. В исследование были включены пациенты в возрасте ≥ 18 лет, госпитализированные в течение 48 часов после начала симптомов, и наблюдались в течение 12 месяцев после выписки. Первичной конечной точкой была выживаемость без рецидива (ВБР), определяемая как время от выписки до повторного инсульта или смерти. Были оценены вероятности выживания, различия в подгруппах и независимые предикторы рецидива. Результаты: В течение периода наблюдения рецидив инсульта был зарегистрирован у 10 из 150 пациентов (6,7%). По данным анализа Kaplan-Meier, 12-месячная безрецидивная выживаемость составила 90,2%, что соотвествует оцененной 12-месячной кумулятивной вероятности рецидива 9,8%. Большинство событий произошло во второй половине периода наблюдения. У пациентов с сахарным диабетом выживаемость без рецидивов была значительно ниже, чем у пациентов без диабета (86,8% против 97,3%, p = 0,009). У пациентов с анамнезом повторного инсульта также наблюдались худшие результаты по сравнению со случаями первого инсульта (84,0% против 96,8%, p = 0,007). Регрессионный анализ Кокса выявил повторный инсульт при поступлении (ОР = 3,83, 95% ДИ 1,09–13,44, p = 0,036) и сахарный диабет (ОР = 3,84, 95% ДИ 1,06–13,84, p = 0,040) как независимые предикторы рецидива. Пол не был значимо связан с исходами. Заключение: Одногодичная выживаемость без рецидивов после инсульта была благоприятной. Однако у пациентов с диабетом и у тех, кто был госпитализирован с повторным инсультом, риск рецидива был выше примерно в 3,8...

  • Open Access

    Evaluation of the Effectiveness of Beck's Scale, FAS, and MHC-SF for Identifying Depressive Episodes and Post-Stroke Fatigue: A Comparative Analysis

    by Akgul Baizullina, Aigul Yermagambetova, Zinat Abdrakhmanova, Arailym Beisbekova, Aiman Oksenbayeva

    Post-stroke fatigue and post-stroke depression are common and debilitating complications that significantly impair recovery, functional status, and quality of life in stroke survivors. However, overlapping symptoms and variability in diagnostic approaches make their accurate assessment challenging. Objective: to comparatively evaluate the reliability, validity, sensitivity, and specificity of the Beck Depression Inventory, Fatigue Assessment Scale, and Mental Health Continuum–Short Form in identifying post-stroke depression and fatigue. Methodology. A comparative literature review was conducted, including 10 peer-reviewed studies published between 2010 and 2024, selected from five major databases based on predefined inclusion criteria. The diagnostic properties of the scales (reliability, validity, sensitivity, and specificity) were systematically analyzed. Conclusions. The findings indicate that the Beck Depression Inventory demonstrates high reliability in screening for depressive symptoms, although its specificity decreases in the presence of post-stroke fatigue. The Fatigue Assessment Scale shows high accuracy in detecting fatigue but does not capture the full spectrum of psychological distress. The Mental Health Continuum–Short Form provides a comprehensive assessment of mental well-being but is less optimal for clinical diagnosis. Overall, the evidence supports a multimodal assessment approach that integrates tools for depression, fatigue, and mental well-being, improving diagnostic accuracy, guiding personalized rehabilitation, and enhancing long-term outcomes in stroke survivors.

  • Open Access

    Bibliometric Analysis of Alpha‐Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson’s Disease

    by Aigerim B. Utegenova, Aigul P. Yermagambetova, Gulnar B. Kabdrakhmanova, Alima A. Khamidulla, Zhanylsyn U. Urasheva, Nazym K. Kenzhinа, Zhanna Zhussupova, Gulzhanat N. Nurlanova

    Study Evaluation: The bibliometric analysis of the published results of the alpha‐synuclein ( α ‐syn) detection study in the peripheral tissues of patients with Parkinson’s disease was carried out by us to study scientific activity and scientific productivity, to measure the quantitative and qualitative characteristics of scientific publications, author productivity, and citation of works, as well as the degree of interrelation between authors, journals, institutes, and countries. Purpose: This study is aimed at bibliometrically analyzing the results of studies on the detection of α ‐syn in peripheral tissue biopsy of patients with Parkinson’s disease from 2013 to 2023. Methods: The data was extracted from the Scopus database collection using an inclusive search strategy. Performance analysis and science mapping were conducted using RStudio v.4.3.1 with the bibliometrix R‐package. The analyzed data encompassed trends in publication and citation and the identification of leading institutions, primary sources, authors, and collaborative countries. Results: A total of 124 relevant studies from 53 different sources were thoroughly analyzed. The analysis included the materials of 843 authors, which together gave an impressive average of 37.67 citations per document over the past decade. The annual growth rate in this area of research, according to calculations, was 10.84%, indicating a steady increase in the number of publications over the study period. The huge volume of research results is highlighted by the inclusion of 231 unique keywords of authors. Conclusion: Studies on the detection of pathological α ‐syn in peripheral tissues for early morphological verification of the diagnosis of Parkinson’s disease are relevant in clinical neurology. α ‐syn detected in the skin biopsy of patients on the basis of this study and data from the world literature meets the requirements for biomarkers.


  • The Use of Amantadine in a Patient with Pneumonia and Parkinson’s Disease: A Case Report

    by A. P. Yermagambetova, G. B. Kabdrakhmanova, A.Z. Mussina, R. B. Kaiyrzhanov, M. M. Zhanuzakova, N. O. Mirova, Z. U. Urasheva

    Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide, with an annual incidence of 8–18 per 100,000 individuals. Its prevalence rises significantly in populations aged 60 and older, with cases projected to double by 2030. While amantadine is well-recognized for managing dyskinesia and as initial monotherapy in PD, its utility in addressing PD decompensation remains insufficiently studied. This report details the case of a 72-year-old Asian woman with PD who developed bilateral lower lobe pneumonia with a prolonged fever. Her condition was marked by worsening motor symptoms, including increased rigidity and tremors. An intravenous infusion of amantadine sulfate was administered, resulting in notable improvements in muscle tone, rigidity, and tremor control. This case highlights the potential role of amantadine in stabilizing motor function during acute systemic stress, such as severe infections. The findings suggest that amantadine sulfate may serve as an effective therapeutic option for PD decompensation in complex clinical scenarios involving comorbid conditions. This case underscores the need for further investigation to define the therapeutic range and establish targeted treatment protocols for PD patients requiring critical care interventions. Keywords: Parkinson’s disease, pneumonia, amantadine, treatment outcome, motor function stabilization

  • Open Access

    Bibliometric Analysis of the Role of Occludin in the Pathogenesis of Stroke

    by Zhanylsyn U. Urasheva, Gulnar B. Kabdrakhmanova, Aigul P. Yermagambetova, Aigerim B. Utegenova, Nazgul A. Seitmaganbetova, Ondassyn M. Aliyev, Saulesh S. Kurmangaliyeva, Nazym K. Kenzhina, Yergen Z. Kurmambayev, Alima A. Khamidulla

    Over the past decade, there has been a notable surge in research dedicated to unraveling the intricate role of tight junction proteins in blood–brain barrier (BBB) damage associated with ischemic stroke. This bibliometric analysis explores the expansive landscape of occludin research, a key tight junction protein, during the years 2000–2023, shedding light on the global scientific contributions, collaborations, and emerging trends in this critical area of stroke pathogenesis. China and the United States emerge as significant contributors, underscoring their prominence in advancing our understanding of tight junction proteins. Occludin, identified as a linchpin in regulating BBB integrity, proves to be a pivotal player, with implications extending to the diagnosis of hemorrhagic transformation in ischemic stroke. This study identifies occludin as a potential biomarker, offering promise for early diagnosis and paving the way for novel diagnostic strategies. The analysis highlights the necessity for a more comprehensive exploration of tight junction proteins, including occludin and claudin‐5, particularly in the context of acute cerebral ischemia. The unique healthcare landscape in Kazakhstan adds urgency to the call for further scientific research in this region, emphasizing the need for tailored investigations to address specific regional challenges. This comprehensive overview not only delineates the current state of occludin research but also signals the direction for future investigations. The identified knowledge gaps and emerging trends provide a roadmap for researchers and policymakers alike, with implications for both scientific discourse and clinical practice. Moving forward, a deeper understanding of tight junction proteins, informed by the insights gleaned from this study, holds the potential to shape targeted therapeutic interventions and diagnostic strategies, ultimately contributing to advancements in global stroke care.


  • Establishing prognostic significance of hypoxia predictors in patients with acute cerebral pathology

    by Zhanslu Sarkulova, Ainur Tokshilykova, Alima Khamidulla, Aigul Utepkaliyeva, Dinmukhamed Ayaganov, Marat Sarkulov, Tomas Tamosuitis

    This research aims to study the prognostic role of serum S100 as a predictor of mortality in vascular and traumatic brain injuries.This prospective cohort study involved 219 patients. In the blood ...


    • 1 January 2020
      • No. 298,p. 84-88

    [PROGNOSTIC VALUE OF BIOMARKERS OF MULTIPLE SCLEROSIS ACTIVITY].

    by A Khamidulla, S Miсhalak, G Kabdrakhmanova, A Utepkaliyeva, Zh Urasheva, Zh Sarkulova, S Arinova

    About 30-40% of multiple sclerosis (MS) patients treated with interferon-beta (IFN-ß) develop neutralizing antibodies (NABs) to IFN-ß. NABs reduce bioavailability of IFN-ß, which leads to a decrease in the therapy effectiveness. The introduction of IFN-ß induce production of several proteins, which are used as markers of the therapy effectiveness. In this study, we assessed the prognostic significance of MS activity biomarkers in relation to the clinical data of MS patients treated with IFN-ß. The study involved 30 MS patients receiving IFN-ß. The average duration of therapy was 3.5 (3.4-5.3) years. The study showed the prevalence of NAbs formation in MS patients was 13% of cases, a year later - 30%. The level of viperin in patients without exacerbations during the observation period was lower than in patients with exacerbations. The study revealed the prognostic significance of viperin in relation to the frequency of exacerbations: viperin concentration above 0.2 ng / ml is a risk factor for exacerbation of MS. The results of this study suggest that viperin concentration in the serum could be used a prognostic marker in MS patients treated with interferons.

    • 1 May 2018
      • No. 278,p. 93-83

    [MODERN APPROACHES TO THE TREATMENT OF MULTIPLE SCLEROSIS (REVIEW AND CLINICAL CASE)].

    by A Khamidulla, G Kabdrakhmanova, Aigul Utepkaliyeva, D Darin, Zh Urasheva

    Multiple sclerosis is a chronic dysimmune neurodegenerative disease of the central nervous system, that affects people of working age and inevitably leads to disability. Treatment of the disease is one of the urgent problems of modern clinical neurology, which is explained by the variety of clinical variants of the flow, the lack of an effective method of treatment. This article is devoted to a review of modern approaches to the issues of etiology, pathogenesis and treatment of multiple sclerosis. Also, the classification of multiple sclerosis depending on the course of the disease, data on modern approaches to the treatment of multiple sclerosis, the criteria for the appointment of differentiated therapy depending on the course of the disease with the use of Disease-Modifying Drugs (DMDs) are given. The main strategies for the use of DMDs are described: escalation and de-escalation. The authors of the article presented a clinical case of observation and treatment of a patient with a remitting-relapsing type of multiple sclerosis with a rapid transformation to the secondary-progressive course. The analysis of the dynamics of clinical manifestations with the reflection of the degree of progression on the EDSS scale, analysis of the the radiological study data, as well as the analysis of the prescription of the drugs of the first-line and the second-line treatment to this patient during the observation period from 2010 to 2017 are given.

  • Open Access

    Current state of brain stroke problem in the West Kazakhstan Region

    by G. B. Kabdrakhmanova, A. P. Utepkaliyeva, Zh. N. Sarkulova, D. B. Darin

    Современное состояние проблемы мозгового инсульта в Западном регионе Казахстана